López-Miranda V - Search Results

1

Cardiovascular Toxicity Induced by Chronic Vincristine Treatment.

Herradón E, González C, González A, Uranga JA, López-Miranda V. Herradón E, et al. Among authors: lopez miranda v. Front Pharmacol. 2021 Jul 21;12:692970. doi: 10.3389/fphar.2021.692970. eCollection 2021. Front Pharmacol. 2021. PMID: 34366848 Free PMC article.

2

Anandamide vehicles: a comparative study.

López-Miranda V, Herradón E, Dannert MT, Alsasua A, Martín MI. López-Miranda V, et al. Eur J Pharmacol. 2004 Nov 28;505(1-3):151-61. doi: 10.1016/j.ejphar.2004.10.017. Eur J Pharmacol. 2004. PMID: 15556148

3

Vasorelaxant effect of Win 55,212-2 in rat aorta: new mechanisms involved.

Dannert MT, Alsasua A, Herradon E, Martín MI, López-Miranda V. Dannert MT, et al. Vascul Pharmacol. 2007 Jan;46(1):16-23. doi: 10.1016/j.vph.2006.06.005. Epub 2006 Jun 16. Vascul Pharmacol. 2007. PMID: 16860612

4

Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.

Herradón E, Martín MI, López-Miranda V. Herradón E, et al. Br J Pharmacol. 2007 Nov;152(5):699-708. doi: 10.1038/sj.bjp.0707404. Epub 2007 Aug 20. Br J Pharmacol. 2007. PMID: 17704831 Free PMC article.

5

Selective lack of tolerance to delayed gastric emptying after daily administration of WIN 55,212-2 in the rat.

Abalo R, Cabezos PA, López-Miranda V, Vera G, González C, Castillo M, Fernández-Pujol R, Martín MI. Abalo R, et al. Neurogastroenterol Motil. 2009 Sep;21(9):1002-e80. doi: 10.1111/j.1365-2982.2009.01315.x. Epub 2009 Apr 21. Neurogastroenterol Motil. 2009. PMID: 19413685

6

Vascular toxicity of chemotherapeutic agents.

López-Miranda V, Herradón E, González C, Martín MI. López-Miranda V, et al. Curr Vasc Pharmacol. 2010 Sep;8(5):692-700. doi: 10.2174/157016110792007012. Curr Vasc Pharmacol. 2010. PMID: 19758112

7

Cytochrome P450 pathway contributes to methanandamide-induced vasorelaxation in rat aorta.

López-Miranda V, Dannert MT, Herradón E, Alsasua A, Martín MI. López-Miranda V, et al. Cardiovasc Drugs Ther. 2010 Dec;24(5-6):379-89. doi: 10.1007/s10557-010-6261-9. Cardiovasc Drugs Ther. 2010. PMID: 20814734

8

Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.

Abalo R, Cabezos PA, Vera G, López-Miranda V, Herradón E, Martín-Fontelles MI. Abalo R, et al. Neurogastroenterol Motil. 2011 May;23(5):457-67, e177. doi: 10.1111/j.1365-2982.2011.01677.x. Epub 2011 Feb 8. Neurogastroenterol Motil. 2011. PMID: 21303434

9

Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia–reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS.

González C, Herradón E, Abalo R, Vera G, Pérez-Nievas BG, Leza JC, Martín MI, López-Miranda V. González C, et al. Diabetes Metab Res Rev. 2011 May;27(4):331-40. doi: 10.1002/dmrr.1176. Diabetes Metab Res Rev. 2011. PMID: 21309057

10

[Resveratrol: a neuroprotective polyphenol in the Mediterranean diet].

López-Miranda V, Soto-Montenegro ML, Vera G, Herradón E, Desco M, Abalo R. López-Miranda V, et al. Rev Neurol. 2012 Mar 16;54(6):349-56. Rev Neurol. 2012. PMID: 22403148 Free article. Review. Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page